Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Biomedical and Environmental Sciences ; (12): 210-215, 2012.
Article in English | WPRIM | ID: wpr-235533

ABSTRACT

<p><b>OBJECTIVE</b>Fungal keratitis (FK) is a vision-threatening infection, whose treatment requires more effective and safer anti-fungal agent exploitation urgently. With this aim, we focused on the effect of an extracellular polysaccharide on fungal adhesion to human corneal epithelial cells.</p><p><b>METHODS</b>We performed the cytotoxicity assays of the extracellular polysaccharide EPS-II from an antarctic bacterium Pseudoaltermonas and evaluated its inhibitory effect on Candida albicans cells' adherence to human corneal epithelial cells (HCECs).</p><p><b>RESULTS</b>EPS-II, which displayed minor cytotoxicity but also promoted proliferation of HCECs, could inhibit the adherence of yeast cells to HCECs in a dose-dependent manner. EPS-II could also suppress the subsequent PI3K/AKT signaling pathway, and thereby decrease the expression of early inflammatory cytokines.</p><p><b>CONCLUSIONS</b>Extracellular polysaccharide EPS-II was suggested as a new natural agent for attenuating FK.</p>


Subject(s)
Humans , Blotting, Western , Candida , Physiology , Cell Adhesion , Cornea , Microbiology , Phosphorylation , Polysaccharides, Bacterial , Pharmacology , Proto-Oncogene Proteins c-akt , Metabolism , Pseudoalteromonas , Metabolism
2.
Acta Pharmaceutica Sinica ; (12): 778-784, 2010.
Article in Chinese | WPRIM | ID: wpr-354533

ABSTRACT

The therapeutic effect of sustained intravitreal injectable voriconazole microspheres (VCZ-MS) on an experimental endophthalmitis of Aspergillus fumigatus was investigated. VCZ-MS was prepared successfully and its physico-chemical property was also evaluated. Right eyes of albino rabbits were infected with an intravitreal injection of 1 000 CFU x mL(-1) of susceptible Aspergillus fumigatus. All fungal endophthalmitis models were randomly divided into five groups 48 hours later: Group A is control group with no treatment; in group B, vitrectomy was performed combined with intravitreal 3 times injections of 100 microg x 0.1 mL(-1) voriconazole every other day. In group C, D and E, vitrectomy was performed combined with intravitreal injection of 0.5 mg, 1.0 mg and 1.5 mg VCZ-MS respectively. The treatment effect was assessed by slit lamp and indirect ophthalmoscope funduscopy examination, using clinical grading system of inflammation in the anterior chamber and the vitreous opacity. The optical microscopy revealed that microspheres obtained from the experiment design were opaque, discrete and spherical particles with smooth surfaces. The drug content and encapsulation efficiency of microspheres were 29.94% and 73.5%, respectively. Endophthalmitis occurred in all eyes of group A, and rapidly developed to panophthalmitis. The inflammation grade of group B, C, D or E was lower than that of group A (P < 0.05). The grade of vitreous opacity in group C, D, E is lower than group B (P < 0.05). Two eyes in group C developed to panophthalmitis. But in group D and E, all eyes whose inflammation was controlled had no recurrence with vitreous clear. Histopathological examination showed normal structures in the cured eyes, while most uncured eyes were atrophic and with eyeball destroyed. So, it can be safely concluded that the curative effect of intravitreal VCZ-MS is significantly better than that of routine intraocular injection of voriconazole. The optimal dose is the one containing 1.0 mg voriconazole.


Subject(s)
Animals , Female , Male , Rabbits , Antifungal Agents , Therapeutic Uses , Aspergillosis , Drug Therapy , Pathology , Aspergillus fumigatus , Delayed-Action Preparations , Endophthalmitis , Drug Therapy , Microbiology , Pathology , Eye , Microbiology , Pathology , Intravitreal Injections , Lactic Acid , Microspheres , Polyglycolic Acid , Pyrimidines , Therapeutic Uses , Random Allocation , Triazoles , Therapeutic Uses , Voriconazole
3.
Acta Pharmaceutica Sinica ; (12): 989-994, 2007.
Article in Chinese | WPRIM | ID: wpr-268541

ABSTRACT

To investigate the inhibitory effect of Pluronic on P-glycoprotein (P-gp) drug efflux pump, Caco-2 cells and animal models were established to study the influence of Pluronic on celiprolol transport across Caco-2 cell monolayer and intestinal mucous membrane with verapamil set as a positive control. Drug concentration was measured by HPLC and the apparent permeability coefficient (P(app)), absorption rate constant (k(a)) and the effective permeability coefficient (P(eff)) were calculated. P(app) of basolateral to apical side and apical to basolateral side was (2.10 +/- 0.13) x 10(-6) and (0.333 +/- 0.018) x 10(-6) cm x s(-1), respectively. Transports of celiprolol across Caco-2 cell monolayer were influenced by both verapamil and Pluronic. The absorption constants (k(a)) of celiprolol at duodenum, jejunum, ileum, and colon were (0.09 +/- 0.03), (0.14 +/- 0.04), (0.11 +/- 0.03) and (0.05 +/- 0.02) h(-1), k(a) of celiprolol in verapamil group were (0.14 +/- 0.03), (0.24 +/- 0.02), (0.25 +/- 0.03) and (0.23 +/- 0.02) h(-1), and k(a) of celiprolol in Pluronic group were (0.13 +/- 0.02), (0.22 +/- 0.02), (0.22 +/- 0.03) and (0.20 +/- 0.03) h(-1), respectively. Pluronic showed significant effect on inhibiting P-gp of Caco-2 cell and intestinal mucosa in rats.


Subject(s)
Animals , Humans , Male , Rats , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Metabolism , Biological Transport , Caco-2 Cells , Celiprolol , Pharmacokinetics , Excipients , Intestinal Absorption , Intestinal Mucosa , Metabolism , Jejunum , Metabolism , Permeability , Poloxamer , Pharmacology , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL